EU regulators reviewing Shire’s bleeding disorder drug
admin 26th June 2017 Uncategorised 0European regulators have validated the marketing authorisation application for Shire’s experimental von Willebrand Disease therapy Veyvondi. More: EU regulators reviewing Shire’s bleeding disorder drug Source: News
read more